DiNuzzo Private Wealth’s BridgeBio Pharma BBIO Stock Holding History

DiNuzzo Private Wealth’s Portfolio BBIO Stock Details BBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.09K	Hold	28	–	–	﹤0.01%	659
2026 Q1	$2.08K	Hold	28	–	–	﹤0.01%	632
2025 Q4	$2.14K	Sell	28 -2	-7%	-$131	﹤0.01%	619
2025 Q3	$1.55K	Buy	30 +5	+20%	+$244	﹤0.01%	735
2025 Q2	$1.08K	Sell	25 -4	-14%	-$145	﹤0.01%	831
2025 Q1	$1K	Buy	29 +12	+71%	+$405	﹤0.01%	821
2024 Q4	$467	Sell	17 -6	-26%	-$155	﹤0.01%	1104
2024 Q3	$586	Buy	23 +1	+5%	+$26	﹤0.01%	1053
2024 Q2	$558	Buy	22 +8	+57%	+$219	﹤0.01%	1008
2024 Q1	$433	Buy	14 +1	+8%	+$34	﹤0.01%	1018
2023 Q4	$525	Buy	+13	New	+$390	﹤0.01%	962

Other funds holding BBIO

Jupiter Topco New York $245B AUM

KKRC

Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

DiNuzzo Private Wealth's BBIO Position: Q2 2026 in Review

DiNuzzo Private Wealth held its BridgeBio Pharma (BBIO) position steady in Q2 2026 at 28 shares worth $2.09K. The position accounts for ﹤0.01% of the portfolio, ranked #659.

DiNuzzo Private Wealth first reported a position in BBIO in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.14K in Q4 2025. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

DiNuzzo Private Wealth held 28 shares of BridgeBio Pharma worth $2.09K as of Q2 2026.
DiNuzzo Private Wealth left its BridgeBio Pharma share count unchanged in Q2 2026.
BridgeBio Pharma made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #659 holding.
DiNuzzo Private Wealth first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 11 quarters since.
DiNuzzo Private Wealth's BridgeBio Pharma position peaked at $2.14K in Q4 2025.
474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.